Overview

Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch

Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
Nautralsitic, Open-label, Single Arm, Uncontrolled Study Evaluating the Effects of Long Acting Injectable (LAI) on Phychosocial Functioning Congitive Functioning and Patient Reported Acceptability of Treatment 'Reported Acceptability of Treatment' Regarding Quality of Life Subjective Well-being Under Neuroleptic Medication in Schizophrenia Patients
Phase:
Phase 4
Details
Lead Sponsor:
Abdi İbrahim Otsuka
Treatments:
Aripiprazole